Clinical Activity of Single Dose Systemic Oncolytic VSV Virotherapy in Patients with Relapsed Refractory T-Cell LymphomaJoselle Cook, Martha Q. Lacy, Thomas E. Witzig et al.|Blood Advances|2022Cited by 44